We represented Nuvem, a portfolio company of Parthenon Capital and a leading provider of healthcare technology solutions specializing in pharmaceuticals, in its acquisition of Louvir, a premier provider of pharmacy analytics solutions serving Federally Qualified Health Centers (FQHCs) and other grantee organizations.
We represented Nuvem, a portfolio company of Parthenon Capital and a leading provider of healthcare technology solutions specializing in pharmaceuticals, in its acquisition of Louvir, a premier provider of pharmacy analytics solutions serving Federally Qualified Health Centers (FQHCs) and other grantee organizations.